CAJ | 학술논문

目的：探讨难治性突聋新的治疗方法。方法回顾性分析44例难治性突聋的临床资料，其中男性24例、女性20例，年龄33岁--68岁，平均47岁，病程2周--2个月。所有病例均在院外做过常规扩血管、营养神经治疗，个别做过高压氧、针灸、理疗等综合治疗，恢复不佳或无恢复。入院后均给予东凌迪芙溶栓治疗一个疗程，并监测纤维蛋白原指标。结果所有44例病人中有34例听力均有明显好转，大部分得到较好的恢复或全部恢复，有效率77.3%。结论对突聋患者行常规方法治疗2周，无效时可结合东凌迪芙溶栓治疗，能有效的改善病人症状恢复听力。
목적：탐토난치성돌롱신적치료방법。방법회고성분석44례난치성돌롱적림상자료，기중남성24례、녀성20례，년령33세--68세，평균47세，병정2주--2개월。소유병례균재원외주과상규확혈관、영양신경치료，개별주과고압양、침구、리료등종합치료，회복불가혹무회복。입원후균급여동릉적부용전치료일개료정，병감측섬유단백원지표。결과소유44례병인중유34례은력균유명현호전，대부분득도교호적회복혹전부회복，유효솔77.3%。결론대돌롱환자행상규방법치료2주，무효시가결합동릉적부용전치료，능유효적개선병인증상회복은력。
Objectives To report an innovative method in treating refractory sudden deafness. Methods Clinical data of 44 cases of refractory sudden deafness were studied retrospectively. The patients included 24 males and 20 females, aged 47 years on average (33 to 68 years), and the disease duration ranged from 2 weeks to 2 months. All cases had undergone and failed the routine vasodilation and neurotrophic therapies, and even unconventional therapies including high-pressure oxygen, acupuncture and physical therapy in a few cases. Batroxobin antithrombosis was provided as one course of treatment, and plas-ma fibrinogen was monitored. Results Significant improvement of hearing occurred in 34 of the 44 cases (77.3%). Conclu-sions Batroxobin antithrombotic therapy seems to be an effective rescue treatment for cases of sudden deafness that have failed the 2 weeks routine treatments, with significant hearing benefits.